Niagen Bioscience, Inc. (NAGE) SEC filings
NAGE SEC filings moved a median of -3.38% by the close. NAGE SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the NAGE overview →
24 measured NAGE SEC filing events.
Where these NAGE SEC filings landedvs 24 measured NAGE SEC filing reactions
| Middle 50% of NAGE SEC filing reactions | -7.99% to -1.18% |
|---|---|
| Median reaction (to close) | -3.38% |
| Measured reactions | 24 |
Point-in-time · zero look-ahead
Half of the 24 NAGE SEC filing events with a measured close landed between -7.99% and -1.18%; 8% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Niagen Bioscience, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.65% | -4.52% | |
| Form 8-K Niagen Bioscience, Inc. For: Aug 04 | SEC filing · Form 8-K | +0.65% | -4.52% | |
| Form EFFECT Niagen Bioscience, Inc. | SEC filing · Form EFFECT | -1.15% | -2.59% | |
| Form 8-K Niagen Bioscience, Inc. For: Jun 24 | SEC filing · Form 8-K | +0.00% | -2.74% | |
| Form S-3 Niagen Bioscience, Inc. | SEC filing · Form S-3 | -0.44% | -3.23% | |
| Form 10-Q Niagen Bioscience, Inc. For: Mar 31 | SEC filing · Form 10-Q | -2.99% | -3.68% | |
| Form 8-K Niagen Bioscience, Inc. For: May 06 | SEC filing · Form 8-K | -2.99% | -3.68% | |
| Form ARS Niagen Bioscience, Inc. For: Dec 31 | SEC filing · Form ARS | +0.63% | -0.42% | |
| Form DEF 14A Niagen Bioscience, Inc. For: Jun 24 | SEC filing · Form DEF | +0.63% | -0.42% | |
| Form DEFA14A Niagen Bioscience, Inc. | SEC filing · Form DEFA14A | +0.63% | -0.42% | |
| Niagen Bioscience Collaborates with USP to Establish First-Ever USP Monograph for Nicotinamide Riboside Chloride (NRCl), the Patented Form in Niagen® | Press release | -0.66% | -1.10% | |
| Form 8-K Niagen Bioscience, Inc. For: Mar 19 | SEC filing · Form 8-K | +3.30% | +0.85% | |
| Form 10-K Niagen Bioscience, Inc. For: Dec 31 | SEC filing · Form 10-K | -5.97% | -10.37% | |
| Form 8-K Niagen Bioscience, Inc. For: Mar 04 | SEC filing · Form 8-K | -5.97% | -10.37% | |
| Form 8-K Niagen Bioscience, Inc. For: Feb 24 | SEC filing · Form 8-K | -0.09% | -3.54% | |
| Form 8-K Niagen Bioscience, Inc. For: Dec 18 | SEC filing · Form 8-K | +0.46% | +2.76% | |
| Form 8-K Niagen Bioscience, Inc. For: Nov 06 | SEC filing · Form 8-K | +5.25% | -7.69% | |
| Form 10-Q Niagen Bioscience, Inc. For: Sep 30 | SEC filing · Form 10-Q | -0.80% | -8.87% | |
| Form 8-K Niagen Bioscience, Inc. For: Nov 04 | SEC filing · Form 8-K | -0.80% | -8.87% | |
| Form 8-K Niagen Bioscience, Inc. For: Oct 06 | SEC filing · Form 8-K | -2.12% | -1.64% | |
| Form S-8 Niagen Bioscience, Inc. | SEC filing · Form S-8 | +0.18% | -1.21% | |
| Form 10-Q Niagen Bioscience, Inc. For: Jun 30 | SEC filing · Form 10-Q | -1.16% | -14.20% | |
| Form 8-K Niagen Bioscience, Inc. For: Aug 06 | SEC filing · Form 8-K | -1.16% | -14.20% | |
| Form 8-K Niagen Bioscience, Inc. For: Jul 25 | SEC filing · Form 8-K | -0.36% | -1.96% |
Keep exploring
More NAGE: earnings → · analyst actions → · NAGE overview →